Neuraxis, INC (NRXS): who owns it and who trades it
As of Nov 16, 2026, NRXS insiders reported 9 purchases worth $1.4M in the last 12 months. The largest buyer was Gil Aharon (Director), with $1M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Neuraxis
From the latest filingsOverall: about as much buying as selling. Famous investors mostly sold. Funds and insiders mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NRXS
32 funds and institutions reported NRXS shares worth $19.2M at the end of Q2 2026, about 24% of the company. The largest holder is AIGH Capital Management LLC with 4.6%.
Funds and institutions (13F) 24%Everyone else 76%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| AIGH Capital Management LLC | 519,938 | 4.65% | $3.8M | +30% |
| Rosalind Advisors, Inc. | 508,055 | 4.54% | $3M | +78% |
| Vanguard Capital Management LLC | 335,793 | 3.00% | $2.5M | +49% |
| Money Concepts Capital Corp | 228,029 | 2.04% | $1.7M | +1% |
| Renaissance Technologies LLC | 169,400 | 1.51% | $1.2M | +120% |
| Marshall Wace, LLP | 128,755 | 1.15% | $941K | +64% |
| Parsons Capital Management Inc | 117,808 | 1.05% | $861K | +1% |
| Panoramic Capital, LLC | 115,000 | 1.03% | $841K | -39% |
| Geode Capital Management, LLC | 96,361 | 0.86% | $705K | +3% |
| Citadel Advisors LLC | 85,053 | 0.76% | $622K | New |
| Eddie Patel Inc | 59,764 | 0.53% | $437K | New |
| Vanguard Fiduciary Trust Co | 59,692 | 0.53% | $436K | +15% |
| BlackRock, Inc. | 58,652 | 0.52% | $429K | +114% |
| State Street Corp | 44,237 | 0.40% | $323K | +15% |
| Centiva Capital, LP | 37,526 | 0.34% | $274K | -26% |
| UBS Group AG | 35,575 | 0.32% | $260K | -22% |
| Northern Trust Corp | 23,083 | 0.21% | $169K | +26% |
| Bridgeway Capital Management, LLC | 17,000 | 0.15% | $124K | New |
| Wealthcare Advisory Partners LLC | 15,188 | 0.14% | $111K | No change |
| Hrt Financial LP | 14,322 | 0.13% | $104K | +43% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NRXS insiders reported $1.4M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Brian Allen Carrico | CEO | Purchase | 268 | $4.84 | $1.3K | Form 4 |
| Oct 8, 2026 | Thomas Joeseph Carrico | CRO | Purchase | 328 | $4.84 | $1.6K | Form 4 |
| Oct 8, 2026 | Timothy Robert Henrichs | CFO | Purchase | 1,937 | $4.84 | $9.4K | Form 4 |
| Apr 1, 2026 | Timothy Robert Henrichs | CFO | Purchase | 7,593 | $1.96 | $14.9K | Form 4 |
| Apr 1, 2026 | Thomas Joeseph Carrico | CRO | Purchase | 667 | $1.96 | $1.3K | Form 4 |
| Apr 1, 2026 | Brian Allen Carrico | CEO | Purchase | 8,060 | $1.96 | $15.8K | Form 4 |
| Feb 12, 2026 | Brian Hannasch | 10% owner | Purchase | 40,000 | $4.92 | $197K | Form 4 |
| Feb 11, 2026 | Brian Hannasch | 10% owner | Purchase | 40,000 | $4.65 | $186K | Form 4 |
| Dec 23, 2025 | Gil Aharon | Director | Purchase | 286,138 | $3.52 | $1M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Gil Aharon | Director | $1M | – | Dec 23, 2025 |
| Brian Hannasch | 10% owner | $383K | – | Feb 12, 2026 |
| Timothy Robert Henrichs | Chief Financial Officer | $24.3K | – | Oct 8, 2026 |
| Brian Allen Carrico | Chief Executive Officer, Director | $17.1K | – | Oct 8, 2026 |
| Thomas Joeseph Carrico | CRO, CCO, CPO | $2.9K | – | Oct 8, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NRXS short interest
Low short interest. 3.6% of NRXS shares are sold short: about 1 share in 28. Over the last 12 reports the number of shares short went up 13%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 455,871 NRXS shares were sold short, 3.6% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 104,420 shares, buying them all back would take about 4.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 455,871 | 3.63% | +10% | 104,420 | 4.4 |
| Oct 15, 2026 | 412,837 | 3.29% | +11% | 177,118 | 2.3 |
| Sep 30, 2026 | 372,805 | 2.97% | -1% | 235,996 | 1.6 |
| Sep 15, 2026 | 377,067 | 3.00% | +52% | 70,108 | 5.4 |
| Aug 31, 2026 | 248,626 | 1.98% | -39% | 67,909 | 3.7 |
| Aug 14, 2026 | 410,751 | 3.27% | -2% | 113,374 | 3.6 |
| Jul 31, 2026 | 418,135 | 3.74% | -11% | 83,695 | 5.0 |
| Jul 15, 2026 | 471,181 | 4.21% | +31% | 60,398 | 7.8 |
| Jun 30, 2026 | 358,654 | 3.21% | -29% | 100,535 | 3.6 |
| Jun 15, 2026 | 507,529 | 4.54% | -2% | 137,726 | 3.7 |
| May 29, 2026 | 520,482 | 4.65% | +29% | 105,000 | 5.0 |
| May 15, 2026 | 402,893 | 3.60% | +2% | 225,625 | 1.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Neuraxis company events
Neuraxis filed 6 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 14, 2026.
- Oct 14, 2026AnnouncementThe Board of Directors of Neuraxis, Inc. authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share for the third quarter of 2026. Filing
- Aug 19, 2026LeadershipCompensatory Arrangements of Certain Officers Stock Option Exchange As previously disclosed, on June 10, 2026, the stockholders of Neuraxis, Inc. approved the cancellation of 1,319,394 outstanding stock options previously granted under the Innovative Health Solutions, Inc. 2017 Stock Compensation… Filing
- Jul 10, 2026AnnouncementThe Board of Directors of Neuraxis, Inc. authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share for the second quarter of 2026. Filing
- Jun 12, 2026VoteReported shareholder vote results. Filing
- Apr 22, 2026AnnouncementAs previously disclosed, on August 29, 2025, the Company entered into an At The Market Offering Agreement with Craig-Hallum Capital Group LLC under which the Company may offer and sell, from time to time at its sole discretion, shares of its $0.001 par value common stock, having an aggregate… Filing
- Apr 21, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Neuraxis financials
Famous investors that hold NRXS
2 of the 50 well-known investors we track reported holding NRXS in their latest 13F filing. The largest position is Jim Simons's, worth $1.2M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 156,300 | $1.2M | 0.0% | -8% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 18,363 | $135K | 0.0% | -78% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named NRXS in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Rosalind Advisors, Inc. | 13D/A | 9.9% |
| Nov 16, 2026 | Rosalind Advisors, Inc. | 13D/A | 9.9% |
| Nov 10, 2026 | BIGGER CAPITAL FUND L P | 13G/A | 5.0% |
| Nov 10, 2026 | BIGGER CAPITAL FUND L P | 13G/A | 5.0% |
Questions about Neuraxis, INC (NRXS) stock
Who owns the most NRXS stock?
The largest reported owner of Neuraxis, INC (NRXS) is AIGH Capital Management LLC, with 4.6% of the company. In total, 32 funds and institutions reported holding NRXS at the end of Q2 2026, together about 24% of the shares. See the largest owners.
Are NRXS insiders buying or selling?
In the last 12 months, NRXS insiders reported 9 open-market purchases worth $1.4M and no sales. The latest trade was on Oct 8, 2026. See every trade.
What is the short interest in NRXS?
As of Oct 30, 2026, 455,871 NRXS shares were sold short, 3.6% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 104,420 shares, buying them all back would take about 4.4 trading days (days to cover). See the history.
Which famous investors hold NRXS?
2 of the 50 well-known investors we track reported NRXS in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $1.2M. See all holders.
Executive pay
Neuraxis's chief executive was paid a total of $936K for the year ended Dec 31, 2025, up 62% from $578K the year before. In the last 12 months, Neuraxis's executives and directors bought $1.1M of stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.